Sports Community Pressures UK Government on ME Research Funding

A letter signed by 360 professional athletes urges UK Prime Minister Rishi Sunak to increase funding for Myalgic Encephalomyelitis (ME) research. Released on 13 October 2023, it highlights the impact of this debilitating illness on 250,000 individuals in the UK.

The athletes, including notable figures from football, rugby, and athletics, argue that ME research suffers from chronic underfunding. According to Action for ME, less than £1 million is allocated annually for research, starkly contrasting with the £336 million spent on cancer research in 2021. Despite affecting about 0.4% of the population, ME funding represents less than 0.03% of the UK’s medical research budget.

“We know the power of perseverance in sports, but for those living with ME, every day is a battle against debilitating fatigue and systemic neglect,” said Clarke Carlisle, a former footballer and campaign signatory. He emphasized the far-reaching effects of inadequate research on patients and families. “It’s time public health policy reflects the scale of the problem.”

Often confused with chronic fatigue syndrome (CFS), ME is marked by extreme fatigue, cognitive impairment, and pain. The World Health Organization classified it as a neurological disease in 1969, yet its underlying mechanisms remain unclear. Recent studies indicate issues with immune regulation and energy metabolism, but large-scale investigations are limited.

The memo from the sports coalition also highlights ME’s underrepresentation in health equity discussions. Addressing ME could provide insights into post-viral syndromes like Long COVID. Dr. Charles Shepherd, Medical Adviser at the ME Association, described this as a "critical opportunity for research crossover."

The letter arrives amid scrutiny of UK health research funding. In January 2023, the House of Commons Science and Technology Committee highlighted the need for research investments to align with disease burden, a principle noted in a 2018 Lancet study that illustrated the funding neglect of ME.

This campaign mirrors grassroots advocacy in other health areas. In 2017, after persistent lobbying, the NIH doubled its funding for ME research. The UK coalition aims to replicate this success by raising awareness.

Barriers remain, however. ME research has faced stigma and mischaracterization. Dr. Shepherd noted that “misguided narratives treating ME as psychosomatic rather than biomedical stymied progress for years.” Skepticism from policymakers regarding funding returns further complicates the issue, given the lack of large-scale studies.

Public health advocates argue that athletes’ involvement sharpens the focus on this critical issue. The coalition’s letter emphasizes that sports promote exploration of human potential, making it essential to ensure equal health access for all facing chronic illnesses.

So far, the government’s response has been cautious. A spokesperson for the Department of Health and Social Care stated, “We recognise the challenges faced by those living with ME and continue to commit to supporting research initiatives where possible.” This acknowledgment lacks specific commitments to increased funding.

Advocates have outlined the potential returns on investment in ME research, including reduced healthcare costs and faster insights into related diseases. An analysis by Invest in ME Research suggests that an additional £20 million over five years could lead to significant advancements, such as diagnostic standardization and biomarker identification.

Critics argue that the government’s hesitance reflects broader budget constraints and the undervaluation of “invisible” illnesses. Nevertheless, campaigners remain hopeful about the coalition's ability to influence policymakers.

“This is the starting whistle,” said athlete-turned-campaigner Ashley Jones. “We won’t stop until those living with ME are given the basic dignity of a fair research allocation.” The coalition plans a parliamentary hearing early next year and aims for 500,000 signatures on a public petition by March 2024.

The letter has reignited discussions about inequitable research funding in the UK. Whether it leads to concrete policy changes depends on persistence and political will.